A retrospective cohort study of the association between smoking and mortality after acute ST-segment elevation myocardial infarction

Background Several studies have shown a ‘smoker's paradox’, where following an acute myocardial infarction, smokers have a paradoxically lower mortality than non-smokers. To date, no large study has investigated this paradox in unselected patients with acute ST-segment elevation myocardial infarction (STEMI) managed by primary percutaneous coronary intervention (PCI) alone. Objectives We aimed to examine the association of smoking status and 1-year mortality in patients who had STEMI managed by primary PCI. Methods This retrospective study included all patients admitted with acute STEMI undergoing primary PCI in a single UK centre from January 2009 to April 2012. The survival status for all patients post-STEMI was obtained. Differences in survival by smoking status were assessed using a Kaplan-Meier curve, and after adjustment for age, gender and additional cardiovascular risk factors using a Cox regression analysis. Results The 1-year mortality for patients with STEMI was 149/1796 (8.3%). There were 846/1796 (47.1%) current smokers, 476/1796 (26.5%) ex-smokers and 417/1796 (23.2%) never smokers. Current smokers were approximately 10 years younger than ex-smokers and never smokers (p=0.001). A multivariate Cox proportional hazards model found no evidence of an association between mortality and smoking status after adjustment; p=0.23. Compared with never smokers, the HR (95% CI) for 1-year mortality for current smokers was 1.47 (0.90 to 2.39) and 1.08 (0.66 to 1.77) for ex-smokers. Conclusions In this retrospective cohort study, we found no evidence of an association between mortality and smoking status in patients with acute STEMI treated with PCI, and thus no evidence of a ‘smoker's paradox’.

[1]  P. Toutouzas,et al.  In-hospital mortality of habitual cigarette smokers after acute myocardial infarction; the "smoker's paradox" in a countrywide study. , 2001, European heart journal.

[2]  J. Deckers,et al.  Smoking behaviour in European patients with established coronary heart disease. , 2006, European heart journal.

[3]  T. Katayama,et al.  The etiology of 'smoker's paradox' in acute myocardial infarction with special emphasis on the association with inflammation. , 2008, International heart journal.

[4]  J. Iqbal,et al.  Pronounced increase in risk of acute ST-segment elevation myocardial infarction in younger smokers , 2016, Heart.

[5]  H. Barron,et al.  Smoking and mortality following acute myocardial infarction: results from the National Registry of Myocardial Infarction 2 (NRMI 2). , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[6]  E. Braunwald,et al.  Predictors of Early Morbidity and Mortality After Thrombolytic Therapy of Acute Myocardial Infarction: Analyses of Patient Subgroups in the Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase II , 1992, Circulation.

[7]  R. Califf,et al.  Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded , 1995, Journal of the American College of Cardiology.

[8]  K. Dickstein,et al.  Comparison of mortality rates after acute myocardial infarction in smokers versus nonsmokers. , 2004, The American journal of cardiology.

[9]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[10]  K. Isaaz,et al.  Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: a multivariate analysis. , 1996, Journal of the American College of Cardiology.

[11]  R. Califf,et al.  Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. , 1995, Circulation.

[12]  J. Iqbal,et al.  A retrospective cross-sectional study on the association between tobacco smoking and incidence of ST-segment elevation myocardial infarction and cardiovascular risk factors , 2015, Postgraduate Medical Journal.

[13]  D. van Klaveren,et al.  Smoking is associated with adverse clinical outcomes in patients undergoing revascularization with PCI or CABG: the SYNTAX trial at 5-year follow-up. , 2015, Journal of the American College of Cardiology.

[14]  J. Røislien,et al.  The "smoker's paradox" in patients with acute coronary syndrome: a systematic review , 2011, BMC medicine.

[15]  Richard Doll,et al.  Mortality in relation to smoking: 22 years' observations on female British doctors. , 1980, British medical journal.

[16]  L. Køber,et al.  The Prognostic Importance of Smoking Status at the Time of Acute Myocardial Infarction in 6676 Patients , 1999, Journal of cardiovascular risk.

[17]  H. White,et al.  Comparison of case fatality in smokers and non-smokers after acute cardiac event , 1997, BMJ.

[18]  E. Gilpin,et al.  Smoking status at the time of acute myocardial infarction and subsequent prognosis. , 1985, American heart journal.

[19]  R. Bhindi,et al.  Absence of a 'smoker's paradox' in field triaged ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention. , 2013, Cardiovascular revascularization medicine : including molecular interventions.

[20]  Z. Siudak,et al.  Impact of smoking status on outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention , 2012, Journal of Thrombosis and Thrombolysis.

[21]  A. Maggioni,et al.  Smoking is not a protective factor for patients with acute myocardial infarction: the viewpoint of the GISSI-2 Study. , 1998, Giornale italiano di cardiologia.

[22]  L. Køber,et al.  Smokers with ST-segment elevation myocardial infarction and short time to treatment have equal effects of PCI and fibrinolysis. , 2012, The Journal of invasive cardiology.

[23]  V. Boyko,et al.  Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey). , 1996, Journal of the American College of Cardiology.

[24]  C. W. Frank,et al.  Prognosis of men after first myocardial infarction: mortality and first recurrence in relation to selected parameters. , 1968, American journal of public health and the nation's health.

[25]  Y. Arbel,et al.  Temporal trends in all-cause mortality of smokers versus non-smokers hospitalized with ST-segment elevation myocardial infarction. , 2014, International journal of cardiology.

[26]  G. Stone,et al.  Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial). , 2011, American Journal of Cardiology.

[27]  P. Mølstad.  First myocardial infarction in smokers. , 1991, European heart journal.

[28]  J. J. Griffin,et al.  Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction--the smoker's paradox revisited. , 2005, American heart journal.

[29]  E. Antman,et al.  Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction. , 2005, Journal of the American College of Cardiology.